Abstract
The introduction of a new test is often slow and obsolete tests are hard to get rid of. After nearly 20 years, the cardiac proteins troponin I and T have not yet replaced the old creatinin kinase myocardial band (CK-MB). International guidelines now recommend the use of troponin as marker for myocardial necrosis and only CK-MB when troponin is not available. However, 23 of 46 Danish laboratories still use CK-MB. The additional cost thus incurred could be used for other beneficial purposes. It is recommended to follow the international guidelines.
| Bidragets oversatte titel | Retirement of creatinkinase MB |
|---|---|
| Originalsprog | Dansk |
| Sider (fra-til) | 3220-3222 |
| Antal sider | 3 |
| Tidsskrift | Ugeskrift for laeger |
| Vol/bind | 170 |
| Udgave nummer | 41 |
| Status | Udgivet - 6 okt. 2008 |
Fingeraftryk
Udforsk hvilke forskningsemner 'Pensionering af kreatininkinase myocardial band' indeholder.Citationsformater
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver